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Patients were followed for at least 3 years (follow-up at 1 yr 98%, at ≥3 yrs
92%). The safety primary end point was a composite of cardiac death and non-
fatal myocardial infarction (with or without stent thrombosis, according to
Academic Research Consortium definitions), and for efficacy target lesion
revascularisation (TLR). Target vessel revascularisation excluding TLR (TVR)
and non TVR were also assessed. 
Results: We included 502 patients (mean age 70 years) presenting with
ACS (52%) or a stable condition (48%), but not acute MI, of who 233 were
diabetic and 381 (76%) were male. During follow-up 30 pts (6%) died, with
cardiac death in 12 pts (2.4%). Nonfatal myocardial infarction occurred in 12
pts (2%). Stent thrombosis was noted in 15 pts (3%): 4 definite (3 acute), 6
probable (1 sub-acute), and 5 possible; 4 acute or sub acute, 4 late and 7 very
late ST. At 3-years, the safety endpoint rate was significantly higher in dia-
betic than in non-diabetic patients (8% vs.1%, p ≤ 0.001), whereas TLR was
not significantly different. 
Conclusions: In everyday practice the PES has a good efficacy with com-
parable clinical parameters for restenosis in DP and NDP at 3 years. PES are
clinically safe, however the risk of paclitaxel stent thrombosis, including very
late ST, is higher for DP. 
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Purpose: The elderly (EL) constitute a rapidly expanding part of our pop-
ulation and cardiovascular disease becomes more prevalent with increasing
age. Encouraging results with the use of drug-eluting stents (DES) has been
presented in patients (pts) with coronary artery disease. In this prospective
study, we assessed the short- and long- term results of DES in diabetic (D) EL,
as compared to younger (YO) pts. 
Methods: A total of 610 consecutive pts (mean age 65±9 years) that had
been treated with DES were classified in 2 groups according to age: 1) YO pts
(N=429, age ≤70 years); 2) EL pts (N=181, age >70 years). Clinical outcome
at follow-up (FU) (median 29 months) was obtained in 98% of pts. Adverse
events at FU were considered death, myocardial infarction (MI), cerebrovas-
cular accident (CVA), bypass surgery (CABG), target (TLR) and non-target
(non-TLR) lesion revascularization. 
Results: EL group had more women (30% vs. 16%, p=0.001), a higher
incidence of hypertensive (85% vs. 77%, p=0.03), with previous CABG (25%
vs. 14%, p=0.001), and ejection fraction < 40% (15% vs. 9%, p=0.05) com-
pared to YO pts. The clinical success rate (angiographic success without death,
Q- wave MI, emergency CABG) was high (>99%) in both groups; more
bleeding complications (1.1% vs. 0%, p=0.09) were observed in EL pts. At FU
a higher rate of death (10.3% vs. 2.8%, p<0.001), CVA (4.6% vs. 0.7%,
p=0.003), and combined death/MI/CVA (15% vs. 6%, p<0.001) was observed
in EL pts; YO pts had a higher rate of non-TLR (19% vs. 11%, p=0.02). Def-
inite and probable stent thrombosis was similar in both groups, but possible
stent thrombosis was higher in EL pts (p=0.02). 
Conclusion: The long-term effectiveness of DES in EL D is lower due to
an increase risk for death or CVA, compared to YO pts.
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Background: novel dedicated ultrafast cardiac cameras had recently be
introduced to improve myocardial perfusion imaging
Objectives: We report the first validation study with thallium-201 and the
new GE Discovery NM 530c CZT cardiac camera.
Methods: We prospectively studied with thallium-201 153 consecu-
tive patients referred for myocardial perfusion imaging at exercise ( 111 to 148
MBq) then redistribution ( with a 37MBq reinjection). 
We performed sequential acquisitions, first with conventional dual head tomo-
graphic Anger camera (CC) in 11 to 16 mn, then with CZT camera (CZT) in
5mn, in prone then in supine position.
Results: 
– we excluded 7 patients: 1 for mispositionning, 1 for camera failure, 1 for
too late acquisition after exercise, 1 for non acceptation of redistribution by the
patient, 1 for motion of the patient.
– acquisition was more comfortable with CZT for all patients.
– counts rate was 3 times more with CZT than with CC ( 3.5 to 5 KCts/s
vs 1 to 1.5 ).
– myocardial counts rate was 6 to 8 times more with CZT than with CC.
– comparison between CZT and CC: quality of CZT images was consid-
ered as better in 38%, equal in 59% and worse in 3% of cases; diagnostic con-
clusions were the same in 137 of 146 cases (94%); discordances were 2
artifacts with CC, 1 artifact with CZT, 4 early redistributions and 2 discor-
dances about reversibility of thallium defect.
– comparison between prone and supine with CZT: quality of prone images
was considered as better in 41%, equal in 34% and worse in 25%; there were
2 times more artifacts in supine (14%) than in prone (7%) (p=0.05).
Conclusions: With thallium-201, the GE Discovery NM 530c CZT cardiac
camera allows 5 minutes acquisitions with an increased image quality and a
reliable diagnosis quality, both in prone and in supine positions.
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Background: Thallium 201 is the most efficient radiotracer for myocardial
perfusion imaging but leads to relative high radiation exposure for patients. 
Objectives: We used a new cardiac CZT camera to decrease the effective
dose with thallium-201 in myocardial perfusion imaging.
Methods: We prospectively studied 137 consecutive patients referred for
stress myocardial perfusion imaging and who previously had in the last 5 years
a myocardial SPECT with thallium-201. We injected at stress a low dose of
thallium 201 (1 to 1.2 MBq/kg, i.e. 74 MBq for 70kgs), performed stress myo-
cardial imaging in 5 to 7 mn with a CZT camera GE Discovery NM 530c and
redistribution imaging when initial images were abnormal, with reinjection
(37MBq) when previous myocardial infarction or severe defect or without
reinjection in other cases. We compared the CZT scan with the scan previ-
ously performed in the last 5 years with conventional dual head tomographic
Anger camera (CC) with a regular dose of thallium-201.
Results: Patients had known coronary artery diseases in 85% of cases,
myocardial scar in 38% and ischemia in 20%.
The average stress dose was 88 MBq versus 125 MBq previously (–30%)
The average time for camera acquisition was 6 mn versus 13 mn (–54%)
The cardiac counts statistic was higher with CZT (>1Mcts)
By comparison with CC, the quality of CZT images was better ( better delin-
eation of left ventricular cavity, visualization of papillary muscles, easier
thickening analysis ) in 70% of cases, equal in 24% and worse in 6% ( 6 arte-
facts, 2 digestive contaminations )
Comparison of artefacts showed 30 unmodified, 29 less and 6 additionnal arte-
facts.
By comparison with the previous SPECT, we missed no pathological image;
furthermore, we detected 5 true pathological images which were missed with
the CC.
Calculated effective dose was less than 12 mSv when no reinjection and less
than 18 mSv when reinjection
Conclusions: With reduced activities of thallium 201 ( -30% ) and effec-
tive doses between 12 and 18 mSv, CZT camera gives reliable high quality
imaging
